Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

146 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gemcitabine increases systemic 5-fluorouracil exposure in advanced cancer patients.
Correale P, Cerretani D, Marsili S, Pozzessere D, Petrioli R, Messinese S, Sabatino M, Roviello F, Pinto E, Francini G, Giorgi G. Correale P, et al. Among authors: petrioli r. Eur J Cancer. 2003 Jul;39(11):1547-51. doi: 10.1016/s0959-8049(03)00361-7. Eur J Cancer. 2003. PMID: 12855261 Clinical Trial.
Folinic acid, 5-fluorouracil and etoposide after curative resection for gastric cancer.
Petrioli R, Sabatino M, Roviello F, Marrelli D, Nastri G, Marsili S, Correale P, Pozzessere D, Messinese S, De Martino A, Tani F, Marzocca G, Lorenzi M, Civitelli S, Tanzini G, Pinto E, Francini G. Petrioli R, et al. Hepatogastroenterology. 2005 Sep-Oct;52(65):1626-30. Hepatogastroenterology. 2005. PMID: 16201130
Continuous oral capecitabine at fixed dose in patients older than 75 years with metastatic colorectal and gastric cancer: a study of the Multidisciplinary Oncology Group on Gastrointestinal Tumors.
Petrioli R, Pascucci A, Francini E, Marsili S, Fiaschi AI, Civitelli S, Tanzini G, Battistelli S, Lorenzi M, Roviello F, Francini G; Multidisciplinary Oncology Group on Gastrointestinal Tumors. Petrioli R, et al. Anticancer Drugs. 2008 Jan;19(1):91-6. doi: 10.1097/CAD.0b013e3282f21363. Anticancer Drugs. 2008. PMID: 18043134
Sequential treatment with epirubicin, oxaliplatin and 5FU (EOF) followed by docetaxel, oxaliplatin and 5FU (DOF) in patients with advanced gastric or gastroesophageal cancer: a single-institution experience.
Petrioli R, Francini E, Roviello F, Marrelli D, Fiaschi AI, Laera L, Rossi G, Bianco V, Brozzetti S, Roviello G. Petrioli R, et al. Cancer Chemother Pharmacol. 2015 May;75(5):941-7. doi: 10.1007/s00280-015-2715-x. Epub 2015 Mar 6. Cancer Chemother Pharmacol. 2015. PMID: 25743995 Clinical Trial.
146 results